Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Aherne

Showing results (21-30 of 139) with videos related to

Pageof 14
Sort By:
Journal of Chromatography|October 31, 1986
Sensitive measurement of glutathione using isocratic high-performance liquid chromatography with fluorescence detectionN K Burton, G W Aherne
Cancer Chemotherapy and Pharmacology|January 1, 1986
The effect of cotrimoxazole on the absorption of orally administered 6-mercaptopurine in the ratN K Burton, G W Aherne
Ecotoxicology and Environmental Safety|February 1, 1985
The role of immunoassay in the analysis of microcontaminants in water samplesG W Aherne, J English, V Marks
Journal of Steroid Biochemistry|March 1, 1990
Radioimmunoassay of the anti-cancer agent 4-hydroxyandrostenedione in body fluidsJ Khubieh, G W Aherne, J Chakraborty
Cancer Chemotherapy and Pharmacology|January 1, 1982
The effect of timing of a single injection on the toxicity of methotrexate in the ratJ English, G W Aherne, V Marks
European Journal of Cancer|August 1, 1973
Cell proliferation in rectal carcinoma and rectal mucosa. A stathmokinetic studyR S Camplejohn, G Bone, W Aherne
Cancer Chemotherapy and Pharmacology|January 1, 1990
Serum kinetics of the anti-cancer agent 4-hydroxyandrostenedione in the ratJ Khubieh, G W Aherne, J Chakraborty
Cancer Chemotherapy and Pharmacology|January 1, 1987
Antibodies to 4-hydroxyandrostenedione--a new anti-breast cancer agent suitable for use in a radioimmunoassayJ Khubieh, G W Aherne, J Chakraborty
British Journal of Urology|June 1, 1982
Combined intravesical therapy with doxorubicin (adriamycin) and urokinase in the management of superficial bladder tumoursO Khan, G W Aherne, G Williams
Clinical Chemistry|January 1, 1982
Evaluation of a commercially available radioimmunoassay kit for measurement of doxorubicin in plasmaE Piall, G W Aherne, V Marks
Pageof 14

Showing results (21-30 of 139) with videos related to

Sort By:
Pageof 14
Journal of Chromatography|October 31, 1986
Sensitive measurement of glutathione using isocratic high-performance liquid chromatography with fluorescence detectionN K Burton, G W Aherne
Cancer Chemotherapy and Pharmacology|January 1, 1986
The effect of cotrimoxazole on the absorption of orally administered 6-mercaptopurine in the ratN K Burton, G W Aherne
Ecotoxicology and Environmental Safety|February 1, 1985
The role of immunoassay in the analysis of microcontaminants in water samplesG W Aherne, J English, V Marks
Journal of Steroid Biochemistry|March 1, 1990
Radioimmunoassay of the anti-cancer agent 4-hydroxyandrostenedione in body fluidsJ Khubieh, G W Aherne, J Chakraborty
Cancer Chemotherapy and Pharmacology|January 1, 1982
The effect of timing of a single injection on the toxicity of methotrexate in the ratJ English, G W Aherne, V Marks
European Journal of Cancer|August 1, 1973
Cell proliferation in rectal carcinoma and rectal mucosa. A stathmokinetic studyR S Camplejohn, G Bone, W Aherne
Cancer Chemotherapy and Pharmacology|January 1, 1990
Serum kinetics of the anti-cancer agent 4-hydroxyandrostenedione in the ratJ Khubieh, G W Aherne, J Chakraborty
Cancer Chemotherapy and Pharmacology|January 1, 1987
Antibodies to 4-hydroxyandrostenedione--a new anti-breast cancer agent suitable for use in a radioimmunoassayJ Khubieh, G W Aherne, J Chakraborty
British Journal of Urology|June 1, 1982
Combined intravesical therapy with doxorubicin (adriamycin) and urokinase in the management of superficial bladder tumoursO Khan, G W Aherne, G Williams
Clinical Chemistry|January 1, 1982
Evaluation of a commercially available radioimmunoassay kit for measurement of doxorubicin in plasmaE Piall, G W Aherne, V Marks
Pageof 14